1:45pm ET
Health and Healthcare
Are Some Cancer Treatments Becoming Too Expensive to Approve?
The topic of acceptable costs versus acceptable results is one that may never have a final conclusion in which everyone agrees.
Companies
/Healthcare
Gilead Sciences Inc
$146.64
▼ $4.36 (−2.88%) today
Markets closed · 1:25am ET
GILD Coverage
Page 17
7:05am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
8:45am ET
Health and Healthcare
Why Have Short Sellers Backed Off Major Biotechs?
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Dolby Labs, Facebook, Freeport-McMoRan, Gilead, GrubHub, Skechers and More
The top analyst upgrades, downgrades and other research calls from Thursday include Dolby Laboratories, Facebook, Freeport-McMoRan, Gilead, GrubHub and Skechers.
4:19pm ET
Health and Healthcare
Gilead Earnings Beat Not Enough For Investors
Gilead reported its most recent quarterly results after the markets closed on Wednesday. The major biotech posted $1.91 in earnings per share (EPS) and $5.65 billion in revenue, versus with consensus estimates…
Chris Lange 12:40pm ET
Health and Healthcare
What to Expect When Gilead Reports
Gilead is scheduled to release its second-quarter financial results after the markets close on Wednesday, and analyst expectations are low.
Chris Lange 7:10am ET
Health and Healthcare
Major Biotechs See a Rising Tide of Short Interest
The July 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
10:25am ET
Health and Healthcare
Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
8:21am ET
Health and Healthcare
Short Sellers Back Off Major Biotechs
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
9:20am ET
Investing
7 Stocks to Buy Now That Will Outperform and Still Be Relevant in 2025
RBC feels these seven top companies will still be very relevant in 2025, and the goods or services they provide potentially will become the norm across the globe. All are great picks…
9:00am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
10:54am ET
Health and Healthcare
Short Sellers Up the Ante For Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest moves in…
10:05am ET
Health and Healthcare
Jefferies Analysts Out With Top Stock Picks Before Big Health Care Conference
While the health care sector as a whole has had its ups and downs, there is no question that mergers and acquisitions can spike interest in the companies fast. Many on Wall…
10:30am ET
Health and Healthcare
Biotech and Pharmaceutical Giants Go All In With Big Data Analytics
It’s no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many of the…
9:40am ET
Health and Healthcare
Short Interest Remains Mixed in Major Biotechs
The May 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.